Brief: Lucid Diagnostics Announces Publication of Analytical Validation Study of EsoGuard
20/08/2024 13:32
Aug 20 (Reuters) - Lucid Diagnostics Inc LUCD.O :
* LUCID DIAGNOSTICS ANNOUNCES PUBLICATION OF ANALYTICAL
VALIDATION
STUDY OF ESOGUARD® FOR EARLY DETECTION OF ESOPHAGEAL PRECANCER
AND CANCER
Source text for Eikon: ID:nPn3YzRGDa
Further company coverage: LUCD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lucid Diagnostics
See all newsLucid Diagnostics Inc reports results for the quarter ended June 30 - Earnings Summary
Lucid Diagnostics Inc expected to post a loss of 7 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE- Lululemon, United Rentals, cannabis stocks
U.S. STOCKS ON THE MOVE- American Airlines, Pot stocks, Paramount Skydance
Lucid Diagnostics falls on $18 mln direct stock deal